WHYUS
We offer a unique blend of broad scientific expertise, global pharma heritage, and unprecedented success in bringing drug discovery projects from conception to the clinic. With a passionate, interdisciplinary and accomplished team, and capabilities ranging from target validation to clinical candidate nomination, we bring great science to your project.
NewsEvents
Our Director of Peptide Chemistry, Elisabetta Bianchi, will be attending and speaking at the 1st International Oligonucleotide and Peptides Conference…
Discovery on Target
Next week our Global Vice President of Sales and Marketing, Heidi Kingdon Jones, and Vice President of North American Business…
IRBM signs agreement with MD Anderson Cancer Center to generate novel immune-checkpoint monoclonal antibodies.
Pomezia, Italy - IRBM today announced the signing of a service and development agreement with The University of Texas MD…
Boston BD
Our Vice President of North American Business Development, Daniel Conlon, will be at the Boston BD conference on September 10.…
IRBMPHOTOS
